You are here

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, 85006 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Ventilator-Associated Pneumonia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- The patient must have or be suspected of having a ventilator-associated pneumonia
(VAP) due to MRSA.

- Patient must be hospitalized for at least 5 days, must be ventilator-dependent ≥ 48
hours prior to screen/baseline, and anticipated to remain on the ventilator for 72
hours after enrollment so follow-up BAL can be performed.

- Clinical picture compatible with pneumonia (acquired during ventilation)

- Chest X Ray at baseline/screen or within 24 hours of initiation of therapy must be
consistent with diagnosis of pneumonia

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Hypersensitivity to linezolid, vancomycin, or one of the excipients in any of these
drug formulations.

- Infections due to gram-positive organisms known to be resistant to either of the study
drugs.

- Any antibiotic used in the treatment of MRSA, such as vancomycin, TMP/SMX, rifampin,
or linezolid, for more than 48 hours prior to patient's enrollment into the study.

- Patients with neutropenia, AIDS, lymphoma or anticipated chemotherapy.

- Patients who have long-term tracheostomy (for more than 60 days). Acute tracheostomy
patients are allowed.

NCT00572559
Pfizer
Completed
Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Nosocomial Pneumonia (NP), Ventilator-associated Pneumonia (VAP)
NCT01808092
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now